The Use of Aspirin to Reduce the Risk of Thrombotic Events in Patients With End-Stage Renal Disease: Protocol for a Randomized Controlled Trial.
Tiago Lemos CerqueiraArmando Fartolino GuerreroClara Krystal Pérez FerminRicardo WangEvelin Elfriede BalbinoJanis L BreezePaola Gonzalez MegoDaniele Argentina SilvaWalid Ezzeldin OmerNathalie Monique VandeveldePublished in: JMIR research protocols (2018)
RR1-10.2196/10516.